Last reviewed · How we verify
Progesterone 200 MG
Progesterone 200 MG is a Small molecule drug developed by Instituto Bernabeu. It is currently FDA-approved. Also known as: Prometrium.
Progesterone 200 MG, marketed by Instituto Bernabeu, is a hormonal therapy currently available in the market. The key composition patent for this drug is set to expire in 2028, providing a clear period of exclusivity. The primary risk lies in the potential increase in competition following the patent expiry.
At a glance
| Generic name | Progesterone 200 MG |
|---|---|
| Also known as | Prometrium |
| Sponsor | Instituto Bernabeu |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. (PHASE4)
- Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea (PHASE3)
- Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy (NA)
- Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF) (NA)
- INTEnsity of ovariaN Stimulation and Embryo Quality (PHASE4)
- Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening (PHASE4)
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification (PHASE2, PHASE3)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progesterone 200 MG CI brief — competitive landscape report
- Progesterone 200 MG updates RSS · CI watch RSS
- Instituto Bernabeu portfolio CI
Frequently asked questions about Progesterone 200 MG
What is Progesterone 200 MG?
Who makes Progesterone 200 MG?
Is Progesterone 200 MG also known as anything else?
What development phase is Progesterone 200 MG in?
Related
- Manufacturer: Instituto Bernabeu — full pipeline
- Also known as: Prometrium
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing